MAPT and Alzheimer disease: In the current study, a mouse model of maternal immune activation (MIA) was utilized to investigate how prenatal immune challenges contribute to long-term alterations in Aβ levels, Tau phosphorylation, and neuroinflammation – crucial players in the pathomechanism of AD.